Medicare beneficiaries face higher costs, reduced services, and possible cuts to the program at large—but there’s good news ...

The Trump administration is turning to an unconventional approach to lowering drug prices in the United States: striking ...

Medicare Part D drugs for conditions like cancer/diabetes will have lower, negotiated prices starting Jan 1, 2026, saving ...

Nearly two-thirds of Americans (64%) believe Medicare benefits will be reduced under the current administration, according to ...

A provision of the summer’s One Big Beautiful Bill Act bumping a slew of orphan drugs from Medicare price negotiation is ...

The One Big Beautiful Bill Act removed a number of orphan drugs from being subject to price negotiations, and this could cost ...

CheapInsurance.com reports that a new $2,000 out-of-pocket cap under Medicare Part D will save millions, but challenges remain in drug pricing and access.

Seniors can switch between Original Medicare and Medicare Advantage, or change Part D drug coverage. Plans change ...

Seniors enrolling in Medicare for 2026 should brace for sharply higher prescription drug prices and fewer policies from which ...

Florida’s 5 million Medicare enrollees will see significant changes in 2026 to premiums, deductibles and choices in plans. Be ...

In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has ...

Prescription drug costs are skyrocketing. Will Medicare Part D bring relief? The law of supply and demand dictates that when competition is scarce, prices will inevitably skyrocket. In the health care ...